After three years of using the Viaskin Peanut patch in children ages 4 to 11, more than half (52 percent)… Read more »
Peanut & Tree Nut
FDA to Review Viaskin Peanut Patch for Possible Approval
DBV Technologies has announced that the FDA has agreed to review the company’s Viaskin Peanut patch for potential regulatory approval.… Read more »
Panel Backs FDA Approval for Aimmune’s Peanut OIT Drug
An expert advisory panel has recommended that the Food and Drug Administration approve Aimmune Therapeutics’ oral immunotherapy (OIT) treatment for… Read more »
Viaskin Peanut Patch Submitted to FDA for Approval Consideration
The manufacturer of the Viaskin Peanut patch has resubmitted its biologics license application (or BLA) to the FDA – in… Read more »
Concerns Raised as ICER Report Praises Peanut Avoidance vs. Therapy
In its final report analyzing the costs and benefits of two novel peanut allergy desensitization products, the Institute for Clinical… Read more »
Peanut Allergy Therapies: ICER’s Review Draws Criticism
What do you get when you undertake a cost-benefit analysis of new therapies when prices have yet to be established… Read more »
Longer Trial Increased Level of Tolerance to AR101 Peanut Therapy
By extending the peanut biologic oral immunotherapy known as AR101 by 28 weeks, a new study finds that a majority… Read more »
Study Favoring Avoidance Over Food Allergy OIT Ignites Controversy
A systematic review of peanut oral immunotherapy that compared 12 controlled studies has brought a longstanding “pro or con” debate… Read more »
After Teens Kicked Off Flight for Allergy, Korean Air Stops Serving Peanut Snacks
Updated April 3, 2019: Korean Air Lines has announced that it will stop serving peanuts as in-flight snacks. The move… Read more »
Documentary Airs on Giorgi Tragedy as Advocacy Moves Ahead
Update: California’s Governor signed the Natalie Giorgi Sunshine Act, described below, into law on July 30, 2019. A California PBS… Read more »